In Silico Trials enable researchers to run thousands of virtual parallel scenarios simultaneously, uncovering rare adverse reactions and critical failure modes that standard clinical trials might miss. The in silico trials market size is expected to reach US$ 12.75 billion by 2034 from US$ 4.64 billion in 2025. The market is anticipated to register a CAGR of 11.9% during 2026–2034. What...